source
- Adagio Medical begins strategic review and cuts over half its workforce amid Nasdaq delisting riskAdagio Medical, a maker of cryoablation devices, announced it is launching a strategic review of its operations. As part of the review, the company will lay off more than half of its full‑time sta…
- Grail's Galleri blood test receives positive FDA advisory panel vote, moving closer to approvalGrail's multi‑cancer blood test Galleri earned a favorable recommendation from the FDA's medical devices advisory committee, bringing the test one step nearer to U.S. market clearance. The panel v…